Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol

British Journal of Pharmacology - Tập 136 Số 4 - Trang 550-557 - 2002
Tim C. Kirkham1, Claire Williams1, Filomena Fezza2, Vincenzo Di Marzo2
1Department of Psychology, University of Reading, Earley Gate, Whiteknights, Reading RG6 6AL
2Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Comprensorio Olivetti, Fabbr. 70, 80078, Pozzuoli (Naples), Italy

Tóm tắt

Endocannabinoids are implicated in appetite and body weight regulation. In rodents, anandamide stimulates eating by actions at central CB1 receptors, and hypothalamic endocannabinoids may be under the negative control of leptin. However, changes to brain endocannabinoid levels in direct relation to feeding or changing nutritional status have not been investigated. We measured anandamide and 2‐arachidonoyl glycerol (2‐AG) levels in feeding‐associated brain regions of rats, during fasting, feeding of a palatable food, or after satiation. Endocannabinoid levels were compared to those in rats fed ad libitum, at a point in their daily cycle when motivation to eat was absent. Fasting increased levels of anandamide and 2‐AG in the limbic forebrain and, to a lesser extent, of 2‐AG in the hypothalamus. By contrast, hypothalamic 2‐AG declined as animals ate. No changes were detected in satiated rats. Endocannabinoid levels in the cerebellum, a control region not directly involved in the control of food intake, were unaffected by any manipulation. As 2‐AG was most sensitive to variation during feeding, and to leptin regulation in a previous study, we examined the behavioural effects of 2‐AG when injected into the nucleus accumbens shell, a limbic forebrain area strongly linked to eating motivation. 2‐AG potently, and dose‐dependently, stimulated feeding. This effect was attenuated by the CB1 receptor antagonist SR141716. These findings provide the first direct evidence of altered brain levels of endocannabinoids, and of 2‐AG in particular, during fasting and feeding. The nature of these effects supports a role for endocannabinoids in the control of appetitive motivation. British Journal of Pharmacology (2002) 136, 550–557; doi:10.1038/sj.bjp.0704767

Từ khóa


Tài liệu tham khảo

10.1016/S0301-0082(98)00087-2

10.1007/s002130050326

10.1042/bj3220671

10.1006/bbrc.1999.0254

10.1007/BF02532386

10.1007/s002130050518

CHAPELOT D., 2000, An endocrine and metabolic definition of the intermeal interval in humans: evidence for a role of leptin on the prandial pattern through fatty acid disposal, Am. J. Clin. Nutr., 7, 421, 10.1093/ajcn/72.2.421

10.1016/S0024-3205(98)00322-1

10.1007/s002130100804

10.1016/S0306-4522(98)00749-0

DEVANE W.A., 1988, Determination and characterization of a cannabinoid receptor in rat brain, Molecular Pharmacol., 34, 605

10.1126/science.1470919

10.1046/j.1471-4159.2000.0741627.x

10.1038/35071088

10.1016/S0195-6663(88)80017-5

10.1016/0952-3278(95)90130-2

10.1038/27376

10.1016/S0091-3057(00)00359-2

10.1111/j.1530-0277.2001.tb02209.x

10.1016/S0014-2999(01)00953-0

10.1126/science.287.5450.125

10.1007/s002130050893

10.1016/S0014-2999(99)00170-3

10.1006/nbdi.1998.0219

10.1073/pnas.061029898

10.1016/S0014-2999(00)00059-5

10.1523/JNEUROSCI.11-02-00563.1991

10.1016/S0165-0173(99)00023-5

10.1038/sj.bjp.0704379

10.1016/S0166-4328(97)00054-5

10.1111/j.1749-6632.1999.tb09262.x

10.1016/S0195-6663(84)80049-5

10.1079/095442201108729141

10.1007/s002130000596

10.1016/S0091-3057(01)00467-1

10.1080/1028415X.2001.11747361

LE FUR G. ARNONE M. RINALDI‐CARMONA M. BARTH F.&HESHMATI H.(2001).SR141716 a selective antagonist of CB1 receptors and obesity. Symposium on the Cannabinoids Burlington Vermont. International Cannabinoid Research Society pp 101.

10.1038/346561a0

10.1016/0006-2952(95)00109-D

10.1038/365061a0

10.1126/science.283.5400.401

RINALDI‐CARMONA M., 1998, SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor, J. Pharmacol. Exp. Ther., 284, 644

SIMIAND J., 1998, SR141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset, Behav. Pharmacol., 9, 179

10.1016/S0166-4328(97)00140-X

10.1523/JNEUROSCI.19-24-11040.1999

10.1006/bbrc.1995.2437

10.1126/science.276.5321.2048

10.1007/BF02244199

10.1016/S0306-4522(97)00436-3

10.1016/S0031-9384(98)00170-X

10.1007/s002130050953

10.1016/S0091-3057(01)00694-3

10.1016/S0031-9384(02)00725-4

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 136 Số 4

550-557

Thông tin tác giả